Literature DB >> 8599973

Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation.

S Y Wang1, L Y Chen, T F Tsai, T S Su, K B Choo, C K Ho.   

Abstract

A panel of two poorly differentiated (HA22T/VGH and SK-Hep-1) and six well-differentiated (HuH-6-cl 5, HuH-7, PLC/PRF/5, Hep G2, Hep 3B, and Tong) human hepatocellular carcinoma (HCC) cell lines were studied for the production of colony-stimulating factors (CSFs) using the granulocyte and macrophage colony formation (CFU-GM) assay, immunocytochemical staining, and Northern blotting. Medium conditioned by untreated HA22T/VGH cells contained a high level of CSFs that could stimulate the in vitro colony formation of human myeloid progenitor cells. The HA22T/VGH cell-derived CSF had an apparent molecular weight of 23 kD. Its activity could be effectively neutralized by antiserum against granulocyte-macrophage CSF (GM-CSF) but not by antibodies to other hematopoietic growth factors, including G-CSF, M-CSF, interleukin-3 (IL-3), and IL-6. Correspondingly, immunocytochemical studies using monoclonal anti-GM-CSF showed a strong positive reaction in the cytoplasm of the HA22T/VGH cells. Northern blot analysis revealed that untreated HA22T/VGH cells expressed a considerable amount of GM-CSF mRNA, confirming that GM-CSF production was constitutive. At optimal concentrations, lipopolysaccharide (LPS), IL-1beta, interferon-gamma (IFN-gamma), and tumor-promoting phorbol diester (TPA) could all stimulate HA22T/VGH cells to secrete GM-CSF. In addition to HA22T/VGH, SK-Hep-1 cells could also produce GM-CSF, although less effectively, whereas all the well-differentiated HCC cell lines tested were negative for CSF production. Morphologic, cytochemical, and immunocytochemical examinations demonstrated that both poorly differentiated CSF-producing HCC cell lines (HA22T/VGH and SK-Hep-1) were macrophage-like in morphology, possessed nonspecific esterase (NSE) activity, and expressed CD14, CD68, and HLA-DR on their surface, while all the well-differentiated HCC cell lines were epithelioid and lacked myeloid differentiation antigens. These results suggest that monocytoid features and CSF production may be differentiation markers of hepatocytes at the immature stages, amd that the HA22T/VGH and SK-Hep-1 cell lines may be valuable tools for the study of hepatic function and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599973

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response.

Authors:  Takako Nomura; Asahiro Morishita; Joji Tani; Kei Takuma; Mai Nakahara; Kyoko Oura; Tomoko Tadokoro; Kiyoyuki Kobayashi; Koji Fujita; Shima Mimura; Hideki Kobara; Kunihiko Tsutsui; Takayuki Sanomura; Yoshihiro Nishiyama; Emi Ibuki; Reiji Haba; Teppei Sakamoto; Hirohito Yoneyama; Takashi Himoto; Tsutomu Masaki
Journal:  Clin J Gastroenterol       Date:  2020-10-17

2.  Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis.

Authors:  T Kinoshita; T Sekiguchi; M J Xu; Y Ito; A Kamiya; K Tsuji; T Nakahata; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

3.  Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival.

Authors:  Anna C Piscaglia; Thomas D Shupe; Giovanbattista Pani; Valentina Tesori; Antonio Gasbarrini; Bryon E Petersen
Journal:  J Hepatol       Date:  2009-04-05       Impact factor: 25.083

4.  Hematopoietic effect of deer antler extract fermented by Bacillus subtilis on murine marrow cells.

Authors:  Yooheon Park; Hyeon-Son Choi; Hyun-Sun Lee; Hyung Joo Suh
Journal:  Nutr Res Pract       Date:  2015-09-10       Impact factor: 1.926

Review 5.  Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes.

Authors:  Hiroaki Nagata; Shuhei Komatsu; Wataru Takaki; Tokunari Okayama; Yasunori Sawabe; Michiaki Ishii; Mitsuo Kishimoto; Eigo Otsuji; Hiroshi Konosu
Journal:  World J Clin Oncol       Date:  2016-10-10

6.  Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma.

Authors:  Meihua Lin; Duo Lv; Yunliang Zheng; Minglan Wu; Chang Xu; Qiao Zhang; Lihua Wu
Journal:  Onco Targets Ther       Date:  2018-05-25       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.